Feedback / Questions
quadrivalent HA nanoparticle influenza and SARS-CoV-2 rS nanoparticle combination vaccine with Matrix-M1 adjuvant (ICC Vaccine) - Novavax
Covovax (NVX-CoV2373) - Novavax, Takeda, Serum Institute of India
http://clinicaltrials.gov/ct2/show/NCT05519839
May 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next